| drug details | | 1 | | name | Amoxicillin | | classification | Penicillin-based antibiotic, broad-spectrum | | pharmacokinetics | Amoxicillin is rapidly absorbed from the gastrointestinal tract. Peak plasma concentrations are reached within 1-2 hours after oral administration. The drug is distributed throughout the body, including tissues and fluids. Renal excretion is the primary route of elimination, with approximately 65-80% of the dose excreted unchanged in urine within 24 hours. | | suggested dosage | 500 mg to 1000 mg every 8 hours, or as prescribed by a physician. | | indications | | 1 | Respiratory tract infections (e.g., bronchitis, pneumonia) | | 2 | Skin and soft tissue infections | | 3 | Urinary tract infections | | 4 | Otitis media |
| | safety in pregnancy | Generally considered safe, but consult a physician before use. Monitor for potential side effects in the newborn. | | safety in breastfeeding | Passes into breast milk in low concentrations. Generally safe when used as prescribed. Consult with a physician. | | side effects | | 1 | Nausea | | 2 | Vomiting | | 3 | Diarrhea | | 4 | Abdominal pain | | 5 | Rash | | 6 | Allergic reactions (e.g., hives, swelling) | | 7 | Severe diarrhea | | 8 | Kidney problems |
| | alternatives | | | contraindications | | 1 | Known allergy to penicillin or other beta-lactam antibiotics | | 2 | Severe kidney problems (may require dosage adjustment) |
| | interactions | | 1 | Oral contraceptives | | 2 | Anticoagulants | | 3 | Certain antacids |
| | warnings and precautions | | 1 | History of gastrointestinal issues (e.g., ulcers, colitis): Use with caution and possibly with antacids. | | 2 | Monitor for signs of hypersensitivity reactions (e.g., rash, difficulty breathing). |
| | additional information | Available in oral tablets, capsules, liquid suspensions, and intravenous formulations. Store according to manufacturer's instructions. | | patient specific | |
| | 2 | | name | Clindamycin | | classification | Lincosamide antibiotic, broad spectrum | | pharmacokinetics | Rapidly absorbed from the gastrointestinal tract, mostly with oral administration, but IV route is available in cases needing parenteral route for infection control. High serum protein binding which allows for a distribution through tissues. Eliminated primarily through hepatic metabolism and renal excretion. | | suggested dosage | 150 to 300 mg orally every 6-8 hours (varies by infection severity). | | indications | | 1 | Skin infections | | 2 | Respiratory infections | | 3 | Abdominal infections |
| | safety in pregnancy | May be used, but consult a physician for individualized recommendations. | | safety in breastfeeding | May be excreted into breast milk; use with caution and monitor as needed. | | side effects | | 1 | Nausea | | 2 | Vomiting | | 3 | Diarrhea | | 4 | Abdominal pain | | 5 | Clostridium difficile-associated diarrhea (C.diff) | | 6 | Other antibiotic-related infections |
| | alternatives | | | contraindications | | 1 | Known hypersensitivity to clindamycin or other lincosamides | | 2 | Severe renal or hepatic impairment |
| | interactions | Possible drug interactions with other antibiotics or medications. Consult with physician. | | warnings and precautions | | 1 | History of diarrhea, antibiotic-associated colitis, or intestinal issues: Monitor closely. | | 2 | Monitor renal and hepatic functions during treatment. |
| | additional information | Available in oral capsules, oral suspensions, and intravenous solutions. |
|
|
